HiberCell

HiberCell’s Genuity buyout brings $100M, plus alliances with Ionis and AbbVie

Startup HiberCell has acquired Genuity Science, a marriage that brings together two companies that apply AI and machine learning to drug research. HiberCell says Genuity will help the company identify and validate new pathways in how cancer starts and progresses.

By Frank Vinluan

BioPharma

Startup HiberCell gets more than $60M to focus on mechanism behind cancer metastasis, recurrence

The New York-based company has two programs in preclinical discovery, based on research conducted at Mount Sinai's Tisch Cancer Institute.

By Alaric DeArment

Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026

Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.

By Tiffany Cabasso, Operations Director, Kyan Health | Psychologist, FSP

Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork

By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

HiberCell’s Genuity buyout brings $100M, plus alliances with Ionis and AbbVie

Startup HiberCell gets more than $60M to focus on mechanism behind cancer metastasis, recurrence

The Power of Real World Data to Study Women’s Health at Scale